Andere talen Hyperfine, Inc.

Aandelen

HYPR

US44916K1060

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,8011 ^USD	-1,10%		-1,10%	-28,47%

17/04	Hyperfine, Inc. Eerste patiënten met Alzheimer die een Amyloid-therapie krijgen in het Care PMR-onderzoek	CI
22/03	HYPERFINE, INC. : Wells Fargo Securities handhaaft het Neutraal advies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Hyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024	29/04
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop System Images across Multiple Care Settings and Clinical Conditions	24/04
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions	23/04
Hyperfine, Inc. - Leading Institutions Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study	18/04
Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study	17/04
Hyperfine, Inc. Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in Care PMR Study	17/04
Earnings Flash (HYPR) HYPERFINE Posts Q4 Revenue $2.7M	21/03
Hyperfine, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/03
Hyperfine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results	21/03
Hyperfine, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	21/03
Hyperfine, Inc. Collaborates with King's College London to Demonstrate the Swoop System and UNITY Project to The Princess Royal	13/03
Hyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal	12/03
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024	07/03
Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference	28/02
Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes	21/02
Hyperfine, Inc. and Athletic Heart Cardiac and Metabolic Testing, Llc Announce Collaboration to Bring Portable Brain Imaging Screening to Current and Former Professional Athletes	21/02
Hyperfine, Inc. Celebrates Breadth of Swoop System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study	02/02
Hyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study	01/02
Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use	09/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Hyperfine, Inc.

Aandelen

HYPR

US44916K1060

Andere talen

Filters